BLESSY JOSEPH: Open Payments
NPI 1043819733 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 6 payments from 5 companies in 2025. Trend: 2023 $692 · 2024 $944 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
Products named: Yeztugo, CAPLYTA, UZEDY, REXULTI, COBENFY.
Industry payments across AZ — which companies pay providers there.
